投资主题筛选
| 代码 |
简称 |
近3年年化 |
对照指数 |
近3年最大回撤 |
近3年夏普 |
动态评分 |
| 980015 |
疫苗生科 |
-13.2% |
11.17% |
-52.47% |
-71.22% |
2.63 |
| CES210 |
中华香港生物科技(全)HKD |
18.27% |
11.17% |
-60.84% |
17.07% |
2.5 |
| CESHKB |
中华香港生物科技 |
15.29% |
11.17% |
-61% |
-7.55% |
2.46 |
| CES110 |
中华香港生物科技(全)CNY |
18.16% |
|
-58.21% |
16.39% |
|
| CES010 |
中华香港生物科技CNY |
17.67% |
|
-58.38% |
15.31% |
|
| CN2339 |
深证科技R |
9.18% |
11.17% |
-36.62% |
4.05% |
0.1 |
| CN2279 |
云科技50R |
24.17% |
11.17% |
-40.11% |
44.2% |
0 |
| CN2363 |
云科技R |
36.14% |
11.17% |
-47% |
64.98% |
0 |
| CN2645 |
100低波R |
8.85% |
11.17% |
-23.95% |
13.12% |
2.29 |
| CN2698 |
优势成长R |
24.81% |
11.17% |
-39.21% |
64.33% |
1.98 |
| CN2699 |
金融科技R |
15.36% |
11.17% |
-47.33% |
40.94% |
2.46 |
| CN2608 |
科技100R |
10.84% |
11.17% |
-40.3% |
5.08% |
0 |
| CN2610 |
TMT50R |
22.37% |
11.17% |
-37.55% |
33.81% |
0 |
| G10113 |
深港通生科 |
|
|
|
|
|
| G10114 |
深港通生科R |
|
|
|
|
|
| G10115 |
深港通生科(港币) |
|
|
|
|
|
| G10116 |
深港通生科R(港币) |
|
|
|
|
|
| H00147 |
优势消费全收益 |
-2.49% |
11.17% |
-36.58% |
-28.15% |
3.05 |
| H00841 |
中证800医药全收益 |
1.47% |
11.17% |
-37.33% |
28.48% |
2.29 |
| H00860 |
结构调整全收益 |
10.23% |
11.17% |
-21.44% |
66.3% |
1.42 |
